NCT00265902

Brief Summary

RATIONALE: Diagnostic procedures, such as infrared thermography, may help find Kaposi's sarcoma and learn the extent of disease. PURPOSE: This clinical trial is studying how well infrared thermography finds skin lesions in patients with Kaposi's sarcoma.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2005

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 3, 2005

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 14, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 15, 2005

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 21, 2006

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 21, 2006

Completed
Last Updated

March 20, 2019

Status Verified

June 1, 2006

Enrollment Period

6 months

First QC Date

December 14, 2005

Last Update Submit

March 18, 2019

Conditions

Sarcoma

Keywords

Kaposi sarcoma

Interventions

diagnostic imagingPROCEDURE

Eligibility Criteria

Age18 Years - 120 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
DISEASE CHARACTERISTICS: * Meets 1 of the following criteria: * Histologically confirmed cutaneous Kaposi's sarcoma (KS) * At least one skin lesion accessible for imaging * HIV positivity with proven cutaneous KS and concurrent visceral or mucous membrane involvement allowed * Healthy volunteer (regardless of HIV status) (control) PATIENT CHARACTERISTICS: Performance status * Not specified Life expectancy * Not specified Hematopoietic * Not specified Hepatic * Not specified Renal * Not specified Other * Pregnancy allowed PRIOR CONCURRENT THERAPY: * Prior topical, intralesional, or systemic treatment allowed

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Baltimore, Maryland, 21231-2410, United States

Location

MeSH Terms

Conditions

SarcomaSarcoma, Kaposi

Interventions

X-Rays

Condition Hierarchy (Ancestors)

Neoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasmsHerpesviridae InfectionsDNA Virus InfectionsVirus DiseasesInfectionsNeoplasms, Vascular Tissue

Intervention Hierarchy (Ancestors)

Electromagnetic RadiationElectromagnetic PhenomenaMagnetic PhenomenaPhysical PhenomenaRadiationRadiation, Ionizing

Study Officials

  • Ciro Martins, MD

    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Purpose
DIAGNOSTIC
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 14, 2005

First Posted

December 15, 2005

Study Start

October 3, 2005

Primary Completion

March 21, 2006

Study Completion

March 21, 2006

Last Updated

March 20, 2019

Record last verified: 2006-06

Locations

US(1)